BRPI0911972A2 - métodos para avaliação de câncer colorretal e composições para o uso dos mesmos - Google Patents

métodos para avaliação de câncer colorretal e composições para o uso dos mesmos

Info

Publication number
BRPI0911972A2
BRPI0911972A2 BRPI0911972A BRPI0911972A BRPI0911972A2 BR PI0911972 A2 BRPI0911972 A2 BR PI0911972A2 BR PI0911972 A BRPI0911972 A BR PI0911972A BR PI0911972 A BRPI0911972 A BR PI0911972A BR PI0911972 A2 BRPI0911972 A2 BR PI0911972A2
Authority
BR
Brazil
Prior art keywords
compositions
methods
colorectal cancer
assessing colorectal
assessing
Prior art date
Application number
BRPI0911972A
Other languages
English (en)
Inventor
M Arndt Greg
Dossey Lesley
Raponi Mitch
Original Assignee
Veridex Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veridex Llc filed Critical Veridex Llc
Publication of BRPI0911972A2 publication Critical patent/BRPI0911972A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0911972A 2008-05-16 2009-05-18 métodos para avaliação de câncer colorretal e composições para o uso dos mesmos BRPI0911972A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5376008P 2008-05-16 2008-05-16
PCT/US2009/044282 WO2009140670A2 (en) 2008-05-16 2009-05-18 Methods for assessing colorectal cancer and compositions for use therein

Publications (1)

Publication Number Publication Date
BRPI0911972A2 true BRPI0911972A2 (pt) 2019-09-24

Family

ID=41319374

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911972A BRPI0911972A2 (pt) 2008-05-16 2009-05-18 métodos para avaliação de câncer colorretal e composições para o uso dos mesmos

Country Status (8)

Country Link
EP (1) EP2283161A4 (pt)
JP (1) JP2011520454A (pt)
KR (1) KR20110015013A (pt)
BR (1) BRPI0911972A2 (pt)
CA (1) CA2725477A1 (pt)
IL (1) IL209078A0 (pt)
MX (1) MX2010012542A (pt)
WO (1) WO2009140670A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201303026A (zh) * 2010-10-08 2013-01-16 Baylor Res Inst 作為鑑別家族性及非家族性結腸直腸癌生物標記之微型核糖核酸（ｍｉＲＮＡ）
ES2548039T3 (es) * 2010-12-01 2015-10-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Modo de predicción del desenlace de un cáncer de colon analizando la expresión de miARN
EP2778237A1 (en) * 2011-01-13 2014-09-17 Industrial Technology Research Institute Biomarkers for recurrence prediction of colorectal cancer
NO3051026T3 (pt) * 2011-10-21 2018-07-28
JP6156621B2 (ja) * 2012-02-14 2017-07-05 国立大学法人 岡山大学 Ａｔｌｌの診断のためのデータ取得方法、ａｔｌｌ診断用キットおよびａｔｌｌ診断システム
WO2013160474A2 (en) * 2012-04-26 2013-10-31 Instituto Aragonés De Ciencias De La Salud miRNAs EXPRESSION IN HEMATOLOGICAL DISEASES
US10260105B2 (en) 2014-02-18 2019-04-16 Baylor Research Institute MiR-320e and colorectal cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2222873A1 (en) * 2007-10-30 2010-09-01 Veridex, LLC Process for monitoring colorectal cancer

Also Published As

Publication number Publication date
CA2725477A1 (en) 2009-11-19
WO2009140670A2 (en) 2009-11-19
MX2010012542A (es) 2010-12-21
IL209078A0 (en) 2011-01-31
JP2011520454A (ja) 2011-07-21
EP2283161A2 (en) 2011-02-16
WO2009140670A9 (en) 2010-03-18
EP2283161A4 (en) 2012-03-28
KR20110015013A (ko) 2011-02-14

Similar Documents

Publication Publication Date Title
BRPI0914007A2 (pt) anatagonistas e agentes de ligação de notch e métodos para uso dos mesmos
BRPI0820980A2 (pt) Composições e métodos para detecção de tiabs
BRPI0912703A2 (pt) composições imuno-moduladoras e métodos para uso dessas
BRPI0822104A2 (pt) Composições antimicrobianas e métodos para o uso das mesmas
BRPI0811635A2 (pt) Compostos de arilazol-2-il cianoetilamino, métodos para fazê-los e métodos para o uso dos mesmos
BRPI0908854A2 (pt) composições e métodos para o tratamento de tumor de origem hematopoética
BRPI0911297A2 (pt) composição e métodos para preparo e uso das mesmas
BRPI0913424A2 (pt) composições agrícolas de baixa taxa de uso e métodos para o uso
BRPI0921569A2 (pt) anticorpos para il-6 e uso dos mesmos
BRPI0813356A2 (pt) Inibidores de proteína quinase e métodos para uso dos mesmos
BRPI1010024A2 (pt) derivados de aminopirrolidinona e uso dos mesmos
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0922122A2 (pt) composições e métodos para tratamento de doença celíaca.
BRPI0921320A2 (pt) composições de anticorpo estáveis e métodos para estabilizar os mesmos
BRPI0907453A2 (pt) Compostos, uso e preparação dos mesmos
BRPI0915928A2 (pt) composições e métodos de uso para anticorpos terapêuticos
BRPI1013347A2 (pt) derivados de quinazolina modulantes da quinase jak e métodos para o uso dos mesmos
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
BRPI0916059A2 (pt) emulsão de cera para uso em produtos de construção
BRPI0906444A2 (pt) Compostos de 4-piridinona e seu uso para câncer
BRPI0907236A2 (pt) inibidores de proteína quinase e uso dos mesmos
BRPI0906478A2 (pt) anticorpo anti-nr10 e uso do mesmo
BRPI0811589A2 (pt) Composição farmacêutica e método para tratar câncer
BR112013010272A2 (pt) métodos analíticos e arranjos para uso nos mesmos
BRPI0907365A2 (pt) Composição antimicrobiana e uso

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.